Forwarded from China in Focus - NTD
Media is too big
VIEW IN TELEGRAM
A German biotechnology company and a Chinese drugmaker are joining forces on a #vaccine project.
The Chinese drugmaker will give #BioNTech $100 million in assets and funding. In return, BioNTech will give the Chinese drugmaker its vaccine manufacturing technology.
🔥Watch the full episode👉https://youtu.be/xIKHTI8QRZU
The Chinese drugmaker will give #BioNTech $100 million in assets and funding. In return, BioNTech will give the Chinese drugmaker its vaccine manufacturing technology.
🔥Watch the full episode👉https://youtu.be/xIKHTI8QRZU
Forwarded from 📡Guardians of Hong Kong
Taiwan says China blocked deal with BioNTech for COVID-19 shots
Taiwan directly accused China for the first time on Wednesday of blocking a deal with Germany's BioNTech SE (22UAy.DE) for COVID-19 vaccines, in an escalating war of words after Beijing offered the shots to the island via a Chinese company.
Taiwan has millions of shots on order, from AstraZeneca Plc (AZN.L) and Moderna Inc (MRNA.O), but has received only slightly more than 700,000 to date, and has only been able to vaccinate about 1% of its population as COVID-19 cases surge.
While Taiwan has previously said it had been unable to sign a final contract with BioNTech, it had only implied that Chinese pressure was to blame
Source: Reuters #May26
https://t.co/FaxIblSll1
#Taiwan #China #BioNTech #Covid19
Taiwan directly accused China for the first time on Wednesday of blocking a deal with Germany's BioNTech SE (22UAy.DE) for COVID-19 vaccines, in an escalating war of words after Beijing offered the shots to the island via a Chinese company.
Taiwan has millions of shots on order, from AstraZeneca Plc (AZN.L) and Moderna Inc (MRNA.O), but has received only slightly more than 700,000 to date, and has only been able to vaccinate about 1% of its population as COVID-19 cases surge.
While Taiwan has previously said it had been unable to sign a final contract with BioNTech, it had only implied that Chinese pressure was to blame
Source: Reuters #May26
https://t.co/FaxIblSll1
#Taiwan #China #BioNTech #Covid19
Forwarded from 📡Guardians of Hong Kong
Countries Signal Doubts About Delta Protection From Chinese Vaccine
Thailand became the latest country to signal waning confidence in a Chinese vaccine against the highly contagious Delta variant, saying it would offer booster shots of Western doses to healthcare workers.
Healthcare workers who received two doses of the vaccine developed by Sinovac Biotech Ltd. would be given a third shot made by either Pfizer Inc. and BioNTech SE or AstraZeneca PLC, Thailand’s health ministry said Monday. Those who had only one dose would receive AstraZeneca as their second.
The decision to mix the vaccines makes Thailand the latest country to show reservations about whether Chinese vaccines work well enough to protect medical workers against the Delta variant, which was first detected in India and is thought to be far more contagious than earlier versions of the virus. The strain has spread to at least 98 countries.
Source: WSJ #Jul13
https://t.co/TkCKN0gyaz
#Thailand #Vaccine #BioNTech #AstraZeneca #Covid19
Thailand became the latest country to signal waning confidence in a Chinese vaccine against the highly contagious Delta variant, saying it would offer booster shots of Western doses to healthcare workers.
Healthcare workers who received two doses of the vaccine developed by Sinovac Biotech Ltd. would be given a third shot made by either Pfizer Inc. and BioNTech SE or AstraZeneca PLC, Thailand’s health ministry said Monday. Those who had only one dose would receive AstraZeneca as their second.
The decision to mix the vaccines makes Thailand the latest country to show reservations about whether Chinese vaccines work well enough to protect medical workers against the Delta variant, which was first detected in India and is thought to be far more contagious than earlier versions of the virus. The strain has spread to at least 98 countries.
Source: WSJ #Jul13
https://t.co/TkCKN0gyaz
#Thailand #Vaccine #BioNTech #AstraZeneca #Covid19